BioXcel Therapeutics (BTAI) Competitors $0.34 0.00 (-0.52%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends BTAI vs. IKNA, ANL, AVTE, RANI, PMVP, CLSD, AVTX, ANIX, UNCY, and GALTShould you be buying BioXcel Therapeutics stock or one of its competitors? The main competitors of BioXcel Therapeutics include Ikena Oncology (IKNA), Adlai Nortye (ANL), Aerovate Therapeutics (AVTE), Rani Therapeutics (RANI), PMV Pharmaceuticals (PMVP), Clearside Biomedical (CLSD), Avalo Therapeutics (AVTX), Anixa Biosciences (ANIX), Unicycive Therapeutics (UNCY), and Galectin Therapeutics (GALT). These companies are all part of the "pharmaceutical products" industry. BioXcel Therapeutics vs. Ikena Oncology Adlai Nortye Aerovate Therapeutics Rani Therapeutics PMV Pharmaceuticals Clearside Biomedical Avalo Therapeutics Anixa Biosciences Unicycive Therapeutics Galectin Therapeutics BioXcel Therapeutics (NASDAQ:BTAI) and Ikena Oncology (NASDAQ:IKNA) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their community ranking, valuation, institutional ownership, earnings, media sentiment, risk, profitability, analyst recommendations and dividends. Which has more volatility & risk, BTAI or IKNA? BioXcel Therapeutics has a beta of -0.01, indicating that its stock price is 101% less volatile than the S&P 500. Comparatively, Ikena Oncology has a beta of 0.49, indicating that its stock price is 51% less volatile than the S&P 500. Which has better earnings and valuation, BTAI or IKNA? Ikena Oncology has higher revenue and earnings than BioXcel Therapeutics. Ikena Oncology is trading at a lower price-to-earnings ratio than BioXcel Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioXcel Therapeutics$1.38M12.37-$179.05M-$2.16-0.16Ikena Oncology$9.16M7.90-$68.17M-$1.23-1.22 Do institutionals & insiders hold more shares of BTAI or IKNA? 30.7% of BioXcel Therapeutics shares are owned by institutional investors. Comparatively, 75.0% of Ikena Oncology shares are owned by institutional investors. 21.2% of BioXcel Therapeutics shares are owned by insiders. Comparatively, 5.9% of Ikena Oncology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth. Is BTAI or IKNA more profitable? Ikena Oncology has a net margin of 0.00% compared to BioXcel Therapeutics' net margin of -3,119.33%. BioXcel Therapeutics' return on equity of 0.00% beat Ikena Oncology's return on equity.Company Net Margins Return on Equity Return on Assets BioXcel Therapeutics-3,119.33% N/A -105.04% Ikena Oncology N/A -36.88%-33.08% Do analysts prefer BTAI or IKNA? BioXcel Therapeutics currently has a consensus price target of $2.81, suggesting a potential upside of 717.59%. Ikena Oncology has a consensus price target of $3.00, suggesting a potential upside of 100.00%. Given BioXcel Therapeutics' higher probable upside, equities analysts plainly believe BioXcel Therapeutics is more favorable than Ikena Oncology.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioXcel Therapeutics 1 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.25Ikena Oncology 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Does the media favor BTAI or IKNA? In the previous week, BioXcel Therapeutics had 1 more articles in the media than Ikena Oncology. MarketBeat recorded 1 mentions for BioXcel Therapeutics and 0 mentions for Ikena Oncology. BioXcel Therapeutics' average media sentiment score of 0.60 beat Ikena Oncology's score of -1.00 indicating that BioXcel Therapeutics is being referred to more favorably in the media. Company Overall Sentiment BioXcel Therapeutics Positive Ikena Oncology Negative Does the MarketBeat Community favor BTAI or IKNA? BioXcel Therapeutics received 214 more outperform votes than Ikena Oncology when rated by MarketBeat users. Likewise, 67.40% of users gave BioXcel Therapeutics an outperform vote while only 58.82% of users gave Ikena Oncology an outperform vote. CompanyUnderperformOutperformBioXcel TherapeuticsOutperform Votes24467.40% Underperform Votes11832.60% Ikena OncologyOutperform Votes3058.82% Underperform Votes2141.18% SummaryBioXcel Therapeutics beats Ikena Oncology on 10 of the 18 factors compared between the two stocks. Get BioXcel Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTAI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTAI vs. The Competition Export to ExcelMetricBioXcel TherapeuticsPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$17.07M$6.23B$5.21B$9.15BDividend YieldN/A2.94%5.13%4.03%P/E Ratio-0.169.6488.4817.36Price / Sales12.37309.351,243.3177.98Price / CashN/A61.4443.7535.97Price / Book-0.186.055.314.79Net Income-$179.05M$154.90M$122.62M$225.00M7 Day Performance-10.37%-0.32%0.61%2.62%1 Month Performance0.88%0.43%2.55%3.81%1 Year Performance-86.61%3.08%25.31%20.10% BioXcel Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTAIBioXcel Therapeutics4.6238 of 5 stars$0.34-0.5%$2.81+717.6%-86.6%$17.07M$1.38M-0.1690IKNAIkena Oncology2.4465 of 5 stars$1.52-2.6%$3.00+97.4%-1.3%$73.35M$659,000.00-1.2470ANLAdlai Nortye1.653 of 5 stars$1.98-0.5%$9.00+354.5%-76.5%$73.06M$5M0.00127Positive NewsGap UpAVTEAerovate Therapeutics1.0591 of 5 stars$2.51-1.6%$2.25-10.4%-87.3%$72.48MN/A-0.8420Positive NewsRANIRani Therapeutics3.6358 of 5 stars$1.26+0.8%$11.71+829.7%-62.0%$72.18M$2.72M-1.19110News CoveragePositive NewsPMVPPMV Pharmaceuticals2.2488 of 5 stars$1.39-4.8%$5.50+295.7%-14.9%$71.93MN/A-1.3950Positive NewsCLSDClearside Biomedical3.2171 of 5 stars$0.94-4.0%$5.33+467.1%-27.9%$71.32M$7.70M-2.0930Positive NewsAVTXAvalo Therapeutics4.0397 of 5 stars$6.84-2.3%$40.00+484.8%+60.3%$71.10M$820,000.000.0040Short Interest ↓ANIXAnixa Biosciences3.3574 of 5 stars$2.20-2.2%$8.50+286.4%-51.4%$70.79M$210,000.00-5.645Positive NewsUNCYUnicycive Therapeutics3.0371 of 5 stars$0.68+2.0%$5.50+711.2%-28.4%$70.37M$680,000.00-0.709GALTGalectin Therapeutics2.1325 of 5 stars$1.12+1.4%$11.00+886.5%-29.1%$69.98MN/A-1.539Positive News Related Companies and Tools Related Companies Ikena Oncology Alternatives Adlai Nortye Alternatives Aerovate Therapeutics Alternatives Rani Therapeutics Alternatives PMV Pharmaceuticals Alternatives Clearside Biomedical Alternatives Avalo Therapeutics Alternatives Anixa Biosciences Alternatives Unicycive Therapeutics Alternatives Galectin Therapeutics Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:BTAI) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredBill Gates’ is about to mint millionaires (again) with Stargate.This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMust-See: 5-Second Trump PredictionPresident Trump's prediction is about to become a reality... Opening a rare window of opportunity for you t...InvestorPlace | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredWarren Buffett Bets $40 Billion—You Can Get in for $20I call it "The Last Retirement Stock You'll Ever Need." Warren Buffett himself owns $40 billion of stock in...Behind the Markets | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioXcel Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioXcel Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTAI Stock Alerts